Month: June 2017

Vigilant Biosciences Commences Studies of Oral Cancer Test June 26, 2017 Vigilant Biosciences Inc, Fort Lauderdale, Fla, has launched patient enrollment for clinical studies of its OncAlert point-of-care qualitative assay in support of its premarket regulatory submission to FDA. Vigilant Biosciences’ initial clinical study is designed to validate performance and evaluate implementation of the OncAlert

Fort Lauderdale biotech firm gets federal grant for oral cancer study June 14, 2017 Fort Lauderdale-based Vigilant Biosciences, which has developed dental and lab toolkits for early detection of oral cancer, has been awarded part of a multi-million dollar grant for a study from the National Institutes of Health. The five-year study will enroll 300

Tests May Detect Oral Cancer Earlier June 2, 2017 Oral and throat cancers can be life-threatening, and their frequency seems to be increasing. Now, two tests that are simple, painless and noninvasive can often detect them at very early stages when they can often be treated successfully. Both were developed here in South Florida. When